NCT04046315 Early Detection of Cardiac Damage With CMR in Women With Breast Cancer Status UNKNOWN Phase N/A
NCT04045522 Study on Bisphosphonates Targeting Triple-negative Breast Cancer Status UNKNOWN Phase N/A
NCT04045496 A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04045392 Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients Status UNKNOWN Phase NA
NCT04042870 Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors Status COMPLETED Phase NA
NCT04042701 DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04042298 Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy Status COMPLETED Phase N/A
NCT04041128 PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer Status COMPLETED Phase EARLY_PHASE1
NCT04040686 HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02 Status COMPLETED Phase EARLY_PHASE1
NCT04040569 A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04039230 Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04038619 Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients Status RECRUITING Phase PHASE1
NCT04038489 COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer Status WITHDRAWN Phase PHASE2
NCT04034953 Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong Status UNKNOWN Phase NA
NCT04033172 Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant ) Status UNKNOWN Phase PHASE2